Bank of Montreal’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-29,415
Closed -$957K 3990
2021
Q3
$957K Sell
29,415
-785
-3% -$24.3K ﹤0.01% 2526
2021
Q2
$1.11M Sell
30,200
-11,897
-28% -$387K ﹤0.01% 2425
2021
Q1
$1.42M Sell
42,097
-20,660
-33% -$763K ﹤0.01% 1959
2020
Q4
$2.34M Buy
62,757
+62,142
+10,104% +$2.26M ﹤0.01% 1752
2020
Q3
$22K Sell
615
-36,819
-98% -$1.07M ﹤0.01% 3806
2020
Q2
$948K Buy
37,434
+2,434
+7% +$57.4K ﹤0.01% 1953
2020
Q1
$548K Buy
35,000
+1,005
+3% +$22.1K ﹤0.01% 1936
2019
Q4
$864K Buy
33,995
+32,783
+2,705% +$656K ﹤0.01% 2356
2019
Q3
$24K Buy
1,212
+37
+3% +$958 ﹤0.01% 4006
2019
Q2
$38K Sell
1,175
-3,413
-74% -$114K ﹤0.01% 3821
2019
Q1
$148K Buy
4,588
+131
+3% +$3.53K ﹤0.01% 2877
2018
Q4
$109K Buy
4,457
+64
+1% +$1.69K ﹤0.01% 2913
2018
Q3
$144K Sell
4,393
-2
-0% -$65 ﹤0.01% 2933
2018
Q2
$156K Buy
4,395
+65
+2% +$2.1K ﹤0.01% 2889
2018
Q1
$142K Buy
+4,330
New +$146K ﹤0.01% 2801

Other funds holding ALBO

Bank of Montreal's ALBO Position: Q4 2021 in Review

Bank of Montreal sold out of Albireo Pharma Inc (ALBO) in Q4 2021, closing a stake of 29,415 shares — an estimated $957K sold.

Bank of Montreal first reported a position in ALBO in Q1 2018 and held it in 15 quarters. The position peaked at $2.34M in Q4 2020. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2021.

  • Bank of Montreal reported no remaining Albireo Pharma Inc position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 29,415 Albireo Pharma Inc shares in Q4 2021, an estimated $957K.
  • Bank of Montreal first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 15 quarters.
  • Bank of Montreal's Albireo Pharma Inc position peaked at $2.34M in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.